Page results
-
The Royal London Hospital for Integrated Medicine (RLHIM) is a centre for evidence-based practice, education and research, specialising in chronic and complex medical conditions. Our mission is to provide a person-centred, holistic approach, including self-care, in order to help people with chronic and complex medical conditions live well and feel better. Our approach considers the whole person and their environment in the quest for optimal health and wellbeing. In order to achieve this, we provide a combination of lifestyle strategies, medical, physical and psychological treatment, as well as advice on safe and appropriate use of complementary therapies. We also deliver and encourage self-care approaches which can continue to be used by patients after discharge. All RLHIM services are outpatient-based and are staffed by experienced healthcare professionals.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
This information is for patients having gynaecology surgery who may also need bowel (colorectal) surgery as part of their cancer treatment.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
This page is designed for parents/carers of children and young people who are scheduled to attend the paediatric audiology department. It outlines the various clinics your child may be seen in on the day of their appointment.
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Information covering a range of conditions. Search by condition name or condition type (specialty).
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
File results
-
FOI/2022/0333 - Maternity care report
-
FOI/2022/0338 - X-ray reporting and interpretation of nasogastric tube placement
-
FOI/2022/0344 - Patient Administration System (PAS) used at Trust
-
FOI/2022/0345 - Contact details for Director of Estates and Facilities
-
FOI/2022/0346 - Renal cell carcinoma and melanoma treatments
-
FOI/2022/0347 - Annual data of service users who received IVF treatment
-
FOI/2022/0352 - Electronic Patient Record (EPR)
-
FOI/2022/0356 - Dog attacks and related injuries
-
FOI/2022/0358 - Infrastructure - data storage
-
FOI/2022/0360 - Staff contact details in charge of catering, vending and beverages